alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › blood-metabolites

blood-metabolites

2 studies tagged blood-metabolites, dated 2016-01-26 to 2021-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease 2021-04-01
  2. Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins 2016-01-26

Studies

2 studies carry this tag.

Date range

2016 to 2021

Top journals

  • Proceedings of the National Academy of Sciences of the United States of America 1
  • Translational psychiatry 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Proceedings of the National Academy of Sciences of the United States of America 2021-04-01 Genetics

    There are currently no disease-modifying treatments for Alzheimer's disease (AD), and an understanding of preclinical causal biomarkers to help target disease pathogenesis in the earliest phases remains elusive.

  2. Blood metabolite markers of neocortical amyloid-β burden: discovery and enrichment using candidate proteins

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Translational psychiatry 2016-01-26 Biomarkers

    We believe this is the first study to investigate associations between blood metabolites and neocortical amyloid burden (NAB) in the search for a blood-based biomarker for Alzheimer's disease (AD).

All topic tags with their study counts